0001209191-19-014941.txt : 20190301 0001209191-19-014941.hdr.sgml : 20190301 20190301160957 ACCESSION NUMBER: 0001209191-19-014941 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190227 FILED AS OF DATE: 20190301 DATE AS OF CHANGE: 20190301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARCUS JOEL S CENTRAL INDEX KEY: 0001216955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36548 FILM NUMBER: 19649402 MAIL ADDRESS: STREET 1: C/O ALEXANDRIA REAL ESTATE EQUITIES, INC STREET 2: 385 E. COLORADO BLVD. SUITE 299 CITY: PASADENA STATE: CA ZIP: 91101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001604464 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 460920988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD STREET 2: SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-278-8930 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD STREET 2: SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-27 0 0001604464 Atara Biotherapeutics, Inc. ATRA 0001216955 MARCUS JOEL S C/O ALEXANDRIA REAL ESTATE EQUITIES, INC 385 EAST COLORADO BOULEVARD, SUITE 299 PASADENA CA 91101 1 0 0 0 Common Stock 2019-02-27 4 M 0 25000 25.15 A 32590 D Common Stock 2019-02-27 4 M 0 10500 24.05 A 43090 D Common Stock 2019-02-27 4 M 0 5500 15.08 A 48590 D Common Stock 2019-02-27 4 M 0 21500 13.20 A 70090 D Common Stock 2019-02-28 4 S 0 62590 36.07 D 7500 D Common Stock 4000 I Held by the Joel S. Marcus and Barbara A. Marcus Family Trust Common Stock 908355 I See footnote Non-Qualified Stock Option (Right to Buy) 25.15 2019-02-27 4 M 0 25000 0.00 D 2022-01-16 Common Stock 25000 0 D Non-Qualified Stock Option (Right to Buy) 24.05 2019-02-27 4 M 0 10500 0.00 D 2023-01-04 Common Stock 10500 0 D Non-Qualified Stock Option (Right to Buy) 15.08 2019-02-27 4 M 0 5500 0.00 D 2024-01-03 Common Stock 5500 0 D Non-Qualified Stock Option (Right to Buy) 13.20 2019-02-27 4 M 0 21500 0.00 D 2024-06-08 Common Stock 21500 0 D The price in Column 4 is a weighted average sale price. The prices actually received ranged from $35.75 to $36.72. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Consists of shares of common stock held by Alexandria Equities, LLC. Mr. Marcus is the Chairman, CEO and Founder of Alexandria Real Estate Equities, Inc., which is the managing member of Alexandria Equities, LLC, which has full voting and investment power with respect to the shares owned by Alexandria Equities, LLC. As an officer of Alexandria Real Estate Equities, Inc., Mr. Marcus may be deemed to have voting and investment power with respect to the shares owned by Alexandria Equities, LLC. Mr. Marcus disclaims beneficial ownership of the shares held by Alexandria Equities, LLC, except to the extent of his underlying pecuniary interest therein. Fully vested. /s/ David Tucker, Attorney-in-Fact 2019-03-01